Mesenchymal lineage heterogeneity underlies nonredundant functions of pancreatic cancer-associated fibroblasts

A framework for advancing our understanding of cancer-associated fibroblasts

Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · see citing works

A global double-fluorescent Cre reporter mouse

Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491 · see citing works

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170 · see citing works

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · see citing works

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609 · see citing works

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590 · see citing works

Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts

Elyada, E., Bolisetty, M., Laise, P., Flynn, W. F., Courtois, E. T., Burkhart, R. A., Teinor, J. A., Belleau, P., Biffi, G., Lucito, M. S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0094 · Cited by 2,241 · see citing works

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195 · see citing works

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100 · see citing works

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085 · see citing works

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443 · see citing works

IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma

Biffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0710 · Cited by 1,360 · see citing works

Diversity and biology of cancer-associated fibroblasts

Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265 · see citing works

Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy

Sherman, M. H., Yu, R. T., Engle, D. D., Ding, N., Atkins, A. R., Tiriac, H., Collisson, E. A., Connor, F., Van Dyke, T., Kozlov, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.007 · Cited by 1,158 · see citing works

Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion

Sousa, C. M., Biancur, D. E., Wang, X., Halbrook, C. J., Sherman, M. H., Zhang, L., Kremer, D., Hwang, R. F., Witkiewicz, A. K., Ying, H., et al. (2016) · Nature · doi:10.1038/nature19084 · Cited by 1,122 · see citing works

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120 · see citing works

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Jiang, H., Hegde, S., Knolhoff, B. L., Zhu, Y., Herndon, J. M., Meyer, M. A., Nywening, T. M., Hawkins, W. G., Shapiro, I. M., Weaver, D. T., et al. (2016) · Nature Medicine · doi:10.1038/nm.4123 · Cited by 1,060 · see citing works

Identification, culture, and characterization of pancreatic stellate cells in rats and humans

Bachem, M. G., Schneider, E., Groß, H., Weidenbach, H., Schmid, R. M., Menke, A., Siech, M., Beger, H. G., Grünert, A., & Adler, G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70209-4 · Cited by 1,017 · see citing works

Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle

He, W., Barak, Y., Hevener, A. L., Olson, P., Liao, D., Le, J., Nelson, M. C., Ong, E. S., Olefsky, J. M., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536828100 · Cited by 978 · see citing works

Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism

Zhao, H., Yang, L., Baddour, J., Achreja, A., Bernard, V., Moss, T., Marini, J. C., Tudawe, T., Seviour, E. G., San Lucas, F. A., et al. (2016) · eLife · doi:10.7554/elife.10250 · Cited by 927 · see citing works

A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration

Buch, T., Heppner, F. L., Tertilt, C., Heinen, T. J. A. J., Kremer, M., Wunderlich, F. T., Jung, S., & Waisman, A. (2005) · Nature Methods · doi:10.1038/nmeth762 · Cited by 922 · see citing works

Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture

Apte, M. V., Haber, P., Applegate, T. L., Norton, I. D., McCaughan, G. W., Korsten, M. A., Pirola, R. C., & Wilson, J. S. (1998) · Gut · doi:10.1136/gut.43.1.128 · Cited by 920 · see citing works

Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer

Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862 · see citing works

Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy

Dominguez, C. X., Müller, S., Keerthivasan, S., Koeppen, H., Hung, J., Gierke, S., Breart, B., Foreman, O., Bainbridge, T. W., Castiglioni, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0644 · Cited by 857 · see citing works

Pancreatic Cancer

Maitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707 · see citing works

Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression

Laklai, H., Miroshnikova, Y. A., Pickup, M. W., Collisson, E. A., Kim, G., Barrett, A., Hill, R. C., Lakins, J. N., Schlaepfer, D. D., Mouw, J. K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4082 · Cited by 598 · see citing works

Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells

Apte, M. V., Park, S., Phillips, P. A., Santucci, N., Goldstein, D., Kumar, R. K., Ramm, G. A., Buchler, M., Friess, H., McCarroll, J. A., et al. (2004) · Pancreas · doi:10.1097/00006676-200410000-00002 · Cited by 591 · see citing works

Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer

Chen, Y., Kim, J., Yang, S., Wang, H., Wu, C.-J., Sugimoto, H., LeBleu, V. S., & Kalluri, R. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.02.007 · Cited by 566 · see citing works

Origin of myofibroblasts in the fibrotic liver in mice

Iwaisako, K., Jiang, C., Zhang, M., Cong, M., Moore-Morris, T. J., Park, T. J., Liu, X., Xu, J., Wang, P., Paik, Y.-H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400062111 · Cited by 535 · see citing works

Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression

Fukuda, A., Wang, S. C., Morris, J. P., Folias, A. E., Liou, A., Kim, G. E., Akira, S., Boucher, K., Firpo, M., Mulvihill, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.002 · Cited by 531 · see citing works

Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells

Rice, A. J., Cortes, E., Lachowski, D., Cheung, B. C. H., Karim, S. A., Morton, J. P., & Hernández, A. E. D. R. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.54 · Cited by 524 · see citing works

Stromal response to Hedgehog signaling restrains pancreatic cancer progression

Lee, J. J., Perera, R. M., Wang, H., Wu, D.-C., Liu, X. S., Han, S., Fitamant, J., Jones, P. D., Ghanta, K. S., Kawano, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411679111 · Cited by 502 · see citing works

Randomized Phase III trial of Pegvorhyaluronidase Alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma

Van Cutsem, E., Tempero, M. A., Sigal, D., Oh, D.-Y., Fazio, N., Macarulla, T., Hitre, E., Hammel, P., Hendifar, A. E., Bates, S. E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00590 · Cited by 499 · see citing works

Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

Weissmueller, S., Manchado, E., Saborowski, M., Morris, J. P., Wagenblast, E., Davis, C. A., Moon, S.-H., Pfister, N. T., Tschaharganeh, D. F., Kitzing, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.066 · Cited by 466 · see citing works

StellaTUM: current consensus and discussion on pancreatic stellate cell research

Erkan, M., Adler, G., Apte, M. V., Bachem, M. G., Buchholz, M., Detlefsen, S., Esposito, I., Frieß, H., Gress, T. M., Habisch, H., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-301220 · Cited by 411 · see citing works

Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis

Zhang, Y., Lazarus, J., Steele, N. G., Yan, W., Lee, H.-J., Nwosu, Z. C., Halbrook, C. J., Menjivar, R. E., Kemp, S. B., Sirihorachai, V. R., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0958 · Cited by 385 · see citing works

A Stromal Lysolipid–Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression

Auciello, F. R., Bulusu, V., Oon, C., Tait-Mulder, J., Berry, M., Bhattacharyya, S., Tumanov, S., Allen-Petersen, B. L., Link, J., Kendsersky, N. D., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1212 · Cited by 332 · see citing works

Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution

Hosein, A. N., Huang, H., Wang, Z., Parmar, K., Du, W., Huang, J., Maitra, A., Olson, E., Verma, U., & Brekken, R. A. (2019) · JCI Insight · doi:10.1172/jci.insight.129212 · Cited by 302 · see citing works

Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma

Neuzillet, C., Tijeras‐Raballand, A., Ragulan, C., Cros, J. F., Patil, Y., Martinet, M., Erkan, M., Kleeff, J. H., Wilson, J. S., Apte, M. V., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5224 · Cited by 296 · see citing works

Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer

Steele, N. G., Biffi, G., Kemp, S. B., Zhang, Y., Drouillard, D., Syu, L.-J., Yuan, H., Oni, T. E., Brosnan, E., Elyada, E., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3715 · Cited by 289 · see citing works

Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment

Helms, E. J., Oñate, M. K., & Sherman, M. H. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1353 · Cited by 283 · see citing works

Bone marrow–derived fibroblasts are a functionally distinct stromal cell population in breast cancer

Raz, Y., Cohen, N., Shani, O., Bell, R. E., Novitskiy, S. V., Abramovitz, L., Levy, C., Milyavsky, M., Leider–Trejo, L., Moses, H. L., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180818 · Cited by 270 · see citing works

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan

Vennin, C., Mélénec, P., Rouet, R., Nobis, M., Cazet, A. S., Murphy, K. J., Herrmann, D., Reed, D. A., Lucas, M. C., Warren, S. C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10968-6 · Cited by 268 · see citing works

Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editingPreprint

Chiou, S., Winters, I. P., Wang, J., Naranjo, S., Dudgeon, C., Tamburini, F. B., Brady Jennifer, J., Yang, D., Grüner, B. M., Chuang, C.-H., et al. (2015) · Genes & Development · doi:10.1101/gad.264861.115 · Cited by 267 · see citing works

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response

Biasci, D., Smoragiewicz, M., Connell, C. M., Wang, Z., Gao, Y., Thaventhiran, J. E. D., Basu, B., Magiera, Ł., Johnson, T. I., Bax, L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013644117 · Cited by 264 · see citing works

Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression

Francescone, R., Costa, D. B. V., Franco‐Barraza, J., Wagner, J., Muir, A., Lau, A. N., Gabitova, L., Pazina, T., Gupta, S., Luong, T., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0775 · Cited by 223 · see citing works

Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704

Manuyakorn, A., Paulus, R., Farrell, J. J., Dawson, N. A., Tze, S., Cheung-Lau, G. C., Hines, O. J., Reber, H. A., Seligson, D. B., Horvath, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5639 · Cited by 216 · see citing works

Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts

Avery, D., Govindaraju, P., Jacob, M., Todd, L., Monslow, J., & Puré, E. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.003 · Cited by 206 · see citing works

Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours

Zhu, Z., Achreja, A., Meurs, N., Animasahun, O., Owen, S., Mittal, A., Parikh, P., Lo, T.-W., Franco-Barraza, J., Shi, J., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0226-5 · Cited by 204 · see citing works

Fate-Mapping Evidence That Hepatic Stellate Cells Are Epithelial Progenitors in Adult Mouse Livers

Yang, L., Jung, Y., Omenetti, A., Witek, R. P., Choi, S. S., VanDongen, H. M. A., Huang, J., Alpini, G. D., & Diehl, A. M. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0115 · Cited by 200 · see citing works

Stromal cues regulate the pancreatic cancer epigenome and metabolome

Sherman, M. H., Yu, R. T., Tseng, T. W., Sousa, C. M., Liu, S., Truitt, M. L., He, N., Ding, N., Liddle, C., Atkins, A. R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620164114 · Cited by 147 · see citing works

Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix

Jiang, H., Torphy, R. J., Steiger, K., Hongo, H., Ritchie, A. J., Kriegsmann, M., Horst, D., Umetsu, S. E., Joseph, N. M., McGregor, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136760 · Cited by 127 · see citing works

Macropinocytosis in cancer-associated fibroblasts is dependent on CaMKK2/ARHGEF2 signaling and functions to support tumor and stromal cell fitness

Zhang, Y., Recouvreux, M. V., Jung, M., Galenkamp, K. M. O., Li, Y., Zagnitko, O., Scott, D. A., Lowy, A. M., & Commisso, C. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0119 · Cited by 116 · see citing works

Differential contribution of pancreatic fibroblast subsets to the pancreatic cancer stroma

Garcia, P. E., Adoumie, M., Kim, E. C., Zhang, Y., Scales, M. K., El-Tawil, Y. S., Shaikh, A. Z., Wen, H.-J., Bednar, F., Allen, B. L., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.05.004 · Cited by 110 · see citing works

Stellate Cells in Tissue Repair, Inflammation, and Cancer

Sherman, M. H. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062855 · Cited by 102 · see citing works

Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma

Torphy, R. J., Wang, Z., True‐Yasaki, A., Volmar, K. E., Rashid, N. U., Yeh, B. M., Johansen, J. S., Hollingsworth, M. A., Yeh, J. J., & Collisson, E. A. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00121 · Cited by 90 · see citing works

β1 integrin–extracellular matrix interactions are essential for maintaining exocrine pancreas architecture and function

Riopel, M., Li, J., Liu, S., Leask, A., & Wang, R. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.147 · Cited by 66 · see citing works

Hepatic stellate cell nomenclature.

Ahern, M., Hall, P. D. L. Μ., Halliday, J., Liddle, C., Olynyk, J. K., Ramm, G. A., Denk, H., Desmet, V., Geerts, A. E., Borojević, R., et al. (1996) · PubMed · Cited by 37 · see citing works

Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic Ducts

Wang, Y., Dorrell, C., Naugler, W. E., Heskett, M. B., Spellman, P. T., Li, B., Galivo, F., Haft, A., Wakefield, L., & Grompe, M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.014 · Cited by 29 · see citing works

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059 · see citing works

Pancreatic cancer: Advances and challenges

Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321 · see citing works

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977 · see citing works

The cancer-immunity cycle: Indication, genotype, and immunotype

Mellman, I., Chen, D. S., Powles, T. B., & Turley, S. J. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.011 · Cited by 985 · see citing works

Cancer-associated fibroblasts in the single-cell era

Lavie, D., Ben‐Shmuel, A., Erez, N., & Scherz‐Shouval, R. (2022) · Nature Cancer · doi:10.1038/s43018-022-00411-z · Cited by 636 · see citing works

Cancer-associated fibroblasts: from basic science to anticancer therapy

Yang, D., Liu, J., Qian, H., & Zhuang, Q. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01013-0 · Cited by 572 · see citing works

Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance

Sherman, M. H., & Beatty, G. L. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031621-024600 · Cited by 481 · see citing works

Activated fibroblasts in cancer: Perspectives and challenges

Caligiuri, G., & Tuveson, D. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.015 · Cited by 431 · see citing works

The splanchnic mesenchyme is the tissue of origin for pancreatic fibroblasts during homeostasis and tumorigenesis

Han, L., Wu, Y., Fang, K., Sweeney, S., Roesner, U. K., Parrish, M., Patel, K., Walter, T., Piermattei, J., Trimboli, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-34464-6 · Cited by 369 · see citing works

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics

Liu, Y., Sinjab, A. F., Min, J., Han, G., Paradiso, F., Zhang, Y., Wang, R., Pei, G., Dai, Y., Liu, Y., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.004 · Cited by 249 · see citing works

Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer

Niu, N., Shen, X., Wang, Z., Chen, Y., Weng, Y., Yu, F., Tang, Y., Lu, P., Liu, M., Wang, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.03.005 · Cited by 238 · see citing works

Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal “unity of ecology and evolution” pathological ecosystem

Luo, W. (2023) · Theranostics · doi:10.7150/thno.82690 · Cited by 233 · see citing works

Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer

Wang, F., Long, J., Li, L., Wu, Z., Da, T.-T., Wang, X., Huang, C., Jiang, Y., Yao, X., Ma, H., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf5464 · Cited by 236 · see citing works

Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin

Foster, D. S., Januszyk, M., Delitto, D., Yost, K. E., Griffin, M., Guo, J. L., Guardino, N. J., Delitto, A. E., Chinta, M. S., Burcham, A. R., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.09.015 · Cited by 220 · see citing works

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma

Zhang, T., Ren, Y., Yang, P., Wang, J., & Zhou, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05351-1 · Cited by 225 · see citing works

EGFR-activated myofibroblasts promote metastasis of pancreatic cancer

Mucciolo, G., Henríquez, J. A., Jihad, M., Teles, S. P., Manansala, J. S., Li, W., Ashworth, S., Lloyd, E. G., Cheng, P. S. W., Luo, W., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.12.002 · Cited by 215 · see citing works

CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion

Günaydın, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668349 · Cited by 205 · see citing works

Targeting CAFs to overcome anticancer therapeutic resistance

Saw, P. E., Chen, J., & Song, E. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.001 · Cited by 198 · see citing works

Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer

Datta, J., Dai, X., Bianchi, A., Silva, I. D. C., Mehra, S., Garrido, V. T., Lamichhane, P., Singh, S. P., Zhou, Z., Dosch, A. R., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2022.07.076 · Cited by 182 · see citing works

Metabolic heterogeneity in cancer

Demicco, M., Liu, X., Leithner, K., & Fendt, S. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00963-z · Cited by 183 · see citing works

Barriers and opportunities in pancreatic cancer immunotherapy

Ju, Y., Xu, D., Liao, M.-M., Sun, Y., Bao, W.-D., Yao, F., & Ma, L. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00681-z · Cited by 167 · see citing works

Analysis of Donor Pancreata Defines the Transcriptomic Signature and Microenvironment of Early Neoplastic Lesions

Carpenter, E. S., Elhossiny, A. M., Kadiyala, P., Li, J., McGue, J. J., Griffith, B. D., Zhang, Y., Edwards, J., Nelson, S., Lima, F., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0013 · Cited by 152 · see citing works

Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment

Xue, M., Zhu, Y., Jiang, Y., Han, L., Shi, M., Su, R. J., Wang, L., Xiong, C., Wang, C., Wang, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40314-w · Cited by 144 · see citing works

Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines

Schwörer, S., Cimino, F. V., Ros, M., Tsanov, K. M., Ng, C., Lowe, S. W., Carmona‐Fontaine, C., & Thompson, C. B. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2316 · Cited by 143 · see citing works

Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context

Kerk, S. A., Lin, L., Myers, A. L., Sutton, D. J., Andren, A., Sajjakulnukit, P., Zhang, L., Zhang, Y., Jiménez, J. A., Nelson, B. S., et al. (2022) · eLife · doi:10.7554/elife.73245 · Cited by 108 · see citing works

From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts

Arpinati, L., & Scherz‐Shouval, R. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.01.007 · Cited by 127 · see citing works

Stromal reprogramming by FAK inhibition overcomes radiation resistance to allow for immune priming and response to checkpoint blockade

Lander, V. E., Belle, J. I., Kingston, N. L., Herndon, J. M., Hogg, G. D., Liu, X., Kang, L.-I., Knolhoff, B. L., Bogner, S. J., Baer, J. M., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0192 · Cited by 114 · see citing works

Epithelial and stromal co-evolution and complicity in pancreatic cancer

Hingorani, S. R. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00530-w · Cited by 108 · see citing works

Integration of Pan-Cancer Single-Cell and Spatial Transcriptomics Reveals Stromal Cell Features and Therapeutic Targets in Tumor Microenvironment

Du, Y., Shi, J., Wang, J., Xun, Z., Yu, Z., Sun, H., Bao, R., Zheng, J., Li, Z., & Ye, Y. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1418 · Cited by 110 · see citing works

Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target

Hartupee, C. D., Nagalo, B. M., Chabu, C. Y., Tesfay, M. Z., Coleman‐Barnett, J., West, J. T., & Moaven, O. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1287459 · Cited by 109 · see citing works

Extrinsic KRAS signaling shapes the pancreatic microenvironment through fibroblast reprogramming

Velez-Delgado, A., Donahue, K. L., Brown, K. L., Du, W., Irizarry-Negron, V., Menjivar, R. E., Lasse Opsahl, E. L., Steele, N. G., The, S., Lazarus, J., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.016 · Cited by 91 · see citing works

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities

Qin, Q., Yu, R., Eriksson, J., Tsai, H., & Zhu, H. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216859 · Cited by 97 · see citing works

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting

Vaish, U., Jain, T., Are, A. C., & Dudeja, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413408 · Cited by 94 · see citing works

Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis

Bai, J.-R., Liu, T., Tu, B., Yuan, M., Shu, Z., Fan, M., Huo, S.-H., Guo, Y., Wang, L.-N., Wang, H., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2093026 · Cited by 91 · see citing works

BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling

Shaashua, L., Ben-Shmuel, A., Pevsner-Fischer, M., Friedman, G., Levi-Galibov, O., Nandakumar, S., Barki, D., Nevo, R., Brown, L. E., Zhang, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34081-3 · Cited by 79 · see citing works

Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer

Mello, A. M., Ngodup, T., Lee, Y., Donahue, K. L., Li, J., Rao, A. U. K., Carpenter, E. S., Crawford, H. C., di Magliano, M. P., & Lee, K. E. (2022) · Oncogenesis · doi:10.1038/s41389-022-00434-2 · Cited by 91 · see citing works

The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth

Manoukian, P., Bijlsma, M. F., & van Laarhoven, H. W. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.743907 · Cited by 89 · see citing works

Collagen architecture and signaling orchestrate cancer development

Su, H., & Karin, M. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.06.002 · Cited by 88 · see citing works

IL-17A-producing CD8 + T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts

Picard, F. S. R., Lutz, V., Brichkina, A. I., Neuhaus, F., Ruckenbrod, T., Hupfer, A., Raifer, H., Klein, M., Bopp, T., Pfefferle, P. I., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-327855 · Cited by 86 · see citing works

Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets

Menezes, S., Okail, M. H., Jalil, S. M. A., Kocher, H. M., & Cameron, A. J. M. (2022) · The Journal of Pathology · doi:10.1002/path.5926 · Cited by 79 · see citing works

The molecular classification of cancer‐associated fibroblasts on a pan‐cancer single‐cell transcriptional atlas

Chen, B., Chan, W. N., Xie, F., Mui, C. W., Liu, X., Cheung, A. H. K., Lung, R. W. M., Chow, C., Zhang, Z., Fang, C., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1516 · Cited by 80 · see citing works

The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities

Masugi, Y. (2022) · Cancers · doi:10.3390/cancers14133293 · Cited by 81 · see citing works

Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer

Raymant, M., Astuti, Y., Álvaro‐Espinosa, L., Green, D. M., Quaranta, V., Bellomo, G., Glenn, M. A., Chandran-Gorner, V., Palmer, D. H., Halloran, C. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47949-3 · Cited by 76 · see citing works

Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis

Kim, S., Leem, G., Choi, J., Koh, Y., Lee, S., Nam, S., Kim, J. S., Park, C. H., Hwang, H. K., Min, K. I., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01287-7 · Cited by 74 · see citing works

Functional heterogeneity of fibroblasts in primary tumors and metastases

Cheng, P. S. W., Zaccaria, M., & Biffi, G. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.11.005 · Cited by 76 · see citing works

PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration

Bell, A. T. F., Mitchell, J. T., Kiemen, A. L., Lyman, M. R., Fujikura, K., Lee, J. W., Coyne, E. M., Shin, S. M., Nagaraj, S., Deshpande, A. M., et al. (2024) · Cell Systems · doi:10.1016/j.cels.2024.07.001 · Cited by 70 · see citing works

Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer

Shakiba, M., & Tuveson, D. A. (2025) · Nature Immunology · doi:10.1038/s41590-025-02134-6 · Cited by 75 · see citing works

The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities

Kung, H., Zheng, K., Zimmerman, J. W., & Zheng, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01077-z · Cited by 69 · see citing works

Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth

Donahue, K. L., Watkoske, H. R., Kadiyala, P., Du, W., Brown, K. L., Scales, M. K., Elhossiny, A. M., Espinoza, C. E., Opsahl, E. L. L., Griffith, B. D., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0100 · Cited by 58 · see citing works

The fibroinflammatory response in cancer

Xiao, Z., & Puré, E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00798-8 · Cited by 60 · see citing works

Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibroblasts with Tumor-Restraining Properties

Cumming, J., Maneshi, P., Dongre, M., Alsaed, T., Dehghan-Nayeri, M. J., Ling, A., Pietras, K., Patthey, C., & Öhlund, D. (2025) · Cancer Research · doi:10.1158/0008-5472.can-23-3252 · Cited by 57 · see citing works

Epigenetic regulation of cancer-associated fibroblast heterogeneity

Kehrberg, R. J., Bhyravbhatla, N., Batra, S. K., & Sushil Kumar, K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188901 · Cited by 55 · see citing works

Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer

Yan, W., Menjivar, R. E., Bonilla, M. E., Steele, N. G., Kemp, S. B., Du, W., Donahue, K. L., Brown, K. L., Carpenter, E. S., Avritt, F. R., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0037 · Cited by 52 · see citing works

Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment

Han, X., Burrows, M., Kim, L. C., Xu, J. P., Vostrejs, W., Le, T. N. V., Poltorack, C. D., Jiang, Y., Cukierman, E., Stanger, B. Z., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114972 · Cited by 56 · see citing works

Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies

Linehan, A., O’Reilly, M., McDermott, R., & O'Kane, G. M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1369136 · Cited by 50 · see citing works

Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer

Zhang, Y., Li, L., Murad, R., Maganti, S., Manceau, A., Faso, H. A., Neff, M., Galapate, C. M., Grenier, S. F., Carrette, F., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.06.021 · Cited by 49 · see citing works

HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation

Chia, L., Wang, B., Kim, J., Luo, L., Shuai, S., Herrera, I., Chen, S. Y., Li, L., Xian, L., Huso, T. H., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci151601 · Cited by 50 · see citing works

An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer

Guo, J., Wang, S., & Gao, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1258538 · Cited by 47 · see citing works

Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer

Veghini, L., Pasini, D., Fang, R., Delfino, P., Filippini, D., Neander, C., Vicentini, C., Fiorini, E., Lupo, F., D’Agosto, S. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54975-8 · Cited by 43 · see citing works

A Quick Guide to CAF Subtypes in Pancreatic Cancer

Brichkina, A. I., Polo, P., Sharma, S. D., Visestamkul, N., & Lauth, M. (2023) · Cancers · doi:10.3390/cancers15092614 · Cited by 40 · see citing works

Targeting Cancer‐Associated Fibroblasts: Eliminate or Reprogram?

Yamazaki, M., & Ishimoto, T. (2025) · Cancer Science · doi:10.1111/cas.16443 · Cited by 40 · see citing works

Cancer-Associated Fibroblasts: Lessons from Pancreatic Cancer

Sherman, M. H., & di Magliano, M. P. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-035400 · Cited by 37 · see citing works

Mucin 5AC–Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity

Ganguly, K., Cox, J. L., Ghersi, D., Grandgenett, P. M., Hollingsworth, M. A., Jain, M., Sushil Kumar, K., & Batra, S. K. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.02.032 · Cited by 39 · see citing works

Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications

Huang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 45 · see citing works

Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance

Murphy, K. J., Chambers, C. R., Herrmann, D., Timpson, P., & Pereira, B. (2021) · Cancers · doi:10.3390/cancers13143481 · Cited by 38 · see citing works

Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment

Tanaka, H. Y., Nakazawa, T., Enomoto, A., Masamune, A., & Kano, M. R. (2023) · Cancers · doi:10.3390/cancers15030724 · Cited by 40 · see citing works

Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer

Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcène, A., & Peulen, O. (2022) · Cancers · doi:10.3390/cancers15010061 · Cited by 37 · see citing works

Roles of differently polarized macrophages in the initiation and progressionof pancreatic cancer

Störz, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237711 · Cited by 36 · see citing works

Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma

Skorupan, N., Domínguez, M. P., Ricci, S. L., & Alewine, C. (2022) · Cancers · doi:10.3390/cancers14174209 · Cited by 32 · see citing works

High Throughput Confined Migration Microfluidic Device for Drug Screening

Yang, Z., Zhou, Z., Si, T., Zhou, Z., Zhou, L., Chin, Y. R., Zhang, L. N., Guan, X., & Yang, M. (2023) · Small · doi:10.1002/smll.202207194 · Cited by 33 · see citing works

Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment

Li, X., Zhou, J., Wang, X., Li, C., Ma, Z., Wan, Q., & Fu, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152312 · Cited by 33 · see citing works

A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer

Wang, R., Hong, K., Zhang, Q., Cao, J., Huang, T., Xiao, Z., Wang, Y., & Shuai, X. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.08.007 · Cited by 32 · see citing works

Sympathetic nerve signaling rewires the tumor microenvironment: a shift in “microenvironmental-ity”

Sattler, A. L., Korzun, T., Gupta, K., Diba, P., Kyprianou, N., & Eksi, S. (2025) · Cancer Metastasis Review · doi:10.1007/s10555-025-10241-x · Cited by 38 · see citing works

Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia

Opitz, F. V., Häberle, L., Daum, A., & Esposito, I. (2021) · Cancers · doi:10.3390/cancers13246188 · Cited by 30 · see citing works

Pancreatic Cancer–Associated Fibroblasts: Where Do We Go from Here?

Carpenter, E. S., Costa, D. B. V., Hasselluhn, M. C., Maitra, A., Olive, K. P., Cukierman, E., di Magliano, M. P., & Sherman, M. H. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-2860 · Cited by 28 · see citing works

Emerging role of pancreatic stellate cell-derived extracellular vesicles in pancreatic cancer

Sarkar, R., Xu, Z., Perera, C. J., & Apte, M. V. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.05.007 · Cited by 28 · see citing works

SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment

Czekay, R., Higgins, C. E., Aydin, H. B., Samarakoon, R., Subasi, N. B., Higgins, S. P., Lee, H., & Higgins, P. J. (2024) · Cells · doi:10.3390/cells13100796 · Cited by 27 · see citing works

Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer

Zhu, J., Zhang, K., Chen, Y., Ge, X., Wu, J., Xu, P., & Yao, J. J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05307-3 · Cited by 30 · see citing works

Extracellular vesicles miR‐31‐5p promotes pancreatic cancer chemoresistance via regulating LATS2‐Hippo pathway and promoting SPARC secretion from pancreatic stellate cells

Qin, C. Y., Zhao, B., Wang, Y., Li, Z., Li, T., Zhao, Y., Wang, W., & Zhao, Y. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12488 · Cited by 26 · see citing works

Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment

Giustarini, G., Teng, G., Pavesi, A., & Adriani, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1156769 · Cited by 27 · see citing works

Insights into the relevance of targeting fibroblasts to control cancer

Boeker, V., & Kalluri, R. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102395 · Cited by 25 · see citing works

Next generation patient derived tumor organoids

Podaza, E., Kuo, H., Nguyen, J., Elemento, O., & Martín, M. L. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.003 · Cited by 24 · see citing works

Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome

Minz, A. P., Mohapatra, D., Dutta, M., Sethi, M., Parida, D., Mohapatra, A. P., Mishra, S., Kar, S., Sasmal, P. K., & Senapati, S. (2023) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-023-03562-9 · Cited by 24 · see citing works

Periostin+ Stromal Cells Guide Lymphovascular Invasion by Cancer Cells

Null, J. L., Kim, D. J., McCann, J. V., Pramoonjago, P., Fox, J. W., Zeng, J., Kumar, P., Edatt, L., Pecot, C. V., & Dudley, A. C. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2412 · Cited by 24 · see citing works

The plasticity of cancer-associated fibroblasts

Xia, Z., & Wever, O. D. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.012 · Cited by 27 · see citing works

Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies

Jia, W., Huang, Z., Zhou, L., Liou, Y., Virgilio, F. D., Ulrich, H., Illés, P., Zhang, W., Huang, C., & Tang, Y. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100988 · Cited by 24 · see citing works

HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis

Mekapogu, A. R., Xu, Z., Pothula, S. P., Perera, C. J., Pang, T., Hosen, S. M. Z., Damalanka, V. C., Janetka, J. W., Goldstein, D., Pirola, R. C., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216286 · Cited by 21 · see citing works

Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma

Arebro, J., Lee, C.-M., Bennewith, K. L., & Garnis, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021300 · Cited by 21 · see citing works

ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression

Ogier, C., Mercy, C. S. A., Bondarenko, E., Wu, Z., Lu, Z., Bui, Q. T., Dhamdhere, M. R., Tang, Y., Recoules, L., Klochkova, A., et al. (2026) · Nature Cancer · doi:10.1101/2023.09.15.557802 · Cited by 25 · see citing works

Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic Cancer

Francescone, R. A., III, Crawford, H. C., & Costa, D. B. V. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.022 · Cited by 20 · see citing works

Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy

Murphy, K. J., Zhu, J., Trpceski, M., Pereira, B., Timpson, P., & Herrmann, D. (2022) · Biochemical Society Transactions · doi:10.1042/bst20220162 · Cited by 19 · see citing works

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging

Saúde-Conde, R., Öztürk, A. A., Stosic, K., Senar, O. A., Navez, J., Bouchart, C., Arsenijevic, T., Flamen, P., & Laethem, J. V. (2024) · Biomedicines · doi:10.3390/biomedicines12030591 · Cited by 20 · see citing works

CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy

Yamashita, K., & Kumamoto, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116003 · Cited by 20 · see citing works

Challenges and Opportunities in Targeting the Complex Pancreatic Tumor Microenvironment

Finan, J. M., Guo, Y., Goodyear, S. M., & Brody, J. R. (2024) · JCO oncology advances. · doi:10.1200/oa-24-00050 · Cited by 20 · see citing works

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts

Liu, Y., Chen, X., Dai, Y., Jia, Y., Kieffer, Y., Xie, L., Zhou, Z., Tyler, L. A., Kim, A. C., Biffi, G., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.06.001 · Cited by 19 · see citing works

SMAD4 and KRAS Status Shapes Cancer Cell–Stromal Cross-Talk and Therapeutic Response in Pancreatic Cancer

Lloyd, E. G., Jihad, M., Manansala, J. S., Li, W., Cheng, P. S. W., Teles, S. P., Mucciolo, G., Henríquez, J. A., Ashworth, S., Luo, W., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2330 · Cited by 18 · see citing works

Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer

Martinez, A. K. F., Döppler, H. R., Bastea, L. I., Edenfield, B. H., Liou, G., & Störz, P. (2022) · iScience · doi:10.1016/j.isci.2022.104327 · Cited by 18 · see citing works

Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer

Bryce, A. S., Dreyer, S. B., Froeling, F. E. M., & Chang, D. K.-F. (2022) · Cancers · doi:10.3390/cancers14215302 · Cited by 18 · see citing works

Hepatic signal transducer and activator of transcription‐3 signalling drives early‐stage pancreatic cancer cachexia via suppressed ketogenesis

Arneson‐Wissink, P. C., Mendez, H., Pelz, K. R., Dickie, J., Bartlett, A. Q., Worley, B. L., Krasnow, S. M., Eil, R. L., & Grossberg, A. J. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13466 · Cited by 17 · see citing works

PLXDC1 + Tumor‐Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma

Du, Y., Zhao, Y., Li, J., Wang, J., You, S., Zhang, Y., Zhang, L., Yang, J., Alinejad‐Rokny, H., Cheng, S., et al. (2025) · Advanced Science · doi:10.1002/advs.202415756 · Cited by 17 · see citing works

Abstract SY23-03: Mesenchymal lineage heterogeneity as a determinant of matrix composition and tumor progression

Sherman, M. H. (2022) · Cancer Research · doi:10.1158/1538-7445.am2022-sy23-03

Abstract IA008: Mechanisms and consequences of pancreatic cancer stromal evolution

Sherman, M. H. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-23-ia008

Abstract I01: Mechanisms and consequences of pancreatic cancer stromal evolution

Sherman, M. H. (2019) · Cancer Research · doi:10.1158/1538-7445.panca19-i01

Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma

Neuzillet, C., Tijeras‐Raballand, A., Ragulan, C., Cros, J. F., Patil, Y., Martinet, M., Erkan, M., Kleeff, J. H., Wilson, J. S., Apte, M. V., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5224 · Cited by 296 · see citing works

Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment

Helms, E. J., Oñate, M. K., & Sherman, M. H. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1353 · Cited by 283 · see citing works